A performance shift was observed in the architect intact PTH assay that has the potential to generate falsely elevated results on patient samples. Results generated in a study using current in-date reagent and calibrator lots, demonstrated a magnitude of shift relative averaging approximately 13 to 45 percent when compared to package insert data. The shift was observed across the full analytical range of the assay.